Document is current

Any future updates will be listed below

Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors

Crossref DOI link: https://doi.org/10.1007/s11239-021-02412-8

Published Online: 2021-03-16

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark